The University of California, San Francisco is part of the University of California system and is a major center of medical and biological research and teaching.
Related Projects:
Academic Manuscript Development
Dr. Tan at UCSF reached out to Facente Consulting for ongoing assistance with manuscript development, literature reviews, and technical editing to support grant submissions, helping to move her academic portfolio forward and support her overall research goals.
Planning for a Mobile, Community-Based, Equity-Centered Research Model
Facente Consulting helped UCSF develop an equity framework for launching their new concept: a shared use mobile van designed to improve community-based research opportunities in San Francisco.
Test and Be Treated (TBT) Study Data Analysis
Facente Consulting helped shape and execute an epidemiological analysis of patterns related to recency of HIV infection at the time of diagnosis in San Francisco, in relation to the COVID-19 pandemic.
Strategic Facilitation to Improve Van-based Hepatitis C Testing and Treatment
The DeLIVER team hired Facente Consulting to facilitate a series of meetings to help them strategize around staff turnover and sustainability, improve financial sustainability, create a community action board, and systematize volunteer engagement.
Strategic Planning for UCSF’s Pain and Addiction Research Center
Facente Consulting supported the UCSF Pain and Addiction Research Center (PARC) in developing a strategic plan to maximize PARC's impact.
Whole-Person Needs Assessment for HIV Care among Women, Infants, Children, and Youth
Facente Consulting conducted a needs assessment to help the Family Care Network at UCSF Benioff Children's Hospital in Oakland, CA better understand how to meet the needs of women, infants, children, and youth living with HIV who use their services.
Research Coordination and Data Analysis for an NIH R21 Study on Hepatitis C Epidemiology
Dr. Facente was a co-investigator on this two-year research study funded by the National Institute on Drug Abuse (NIDA), with the goal of better understanding the epidemiology of hepatitis C in three high-burden subpopulations in San Francisco.